Scale AI on Wednesday announced a deal with the Department of Defense for a flagship AI agent program, a significant move in the controversial military use of artificial intelligence.
Read more here.
Scale AI on Wednesday announced a deal with the Department of Defense for a flagship AI agent program, a significant move in the controversial military use of artificial intelligence.
Read more here.
![[SaNOtize in Business Wire] Phase 3 Clinical Trial Confirms SaNOtize’s Breakthrough Treatment is 99% Effective Against COVID-19; Receives Regulatory Approval in India](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
